BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Amgen R&D Cost-Share Liability by Year
Amgen R&D Cost-Share Liability — Total Carrying Value ($M) ($M)
BeOne Medicines Amgen R&D Cost-Share Liability: $64.3M in FY2025, down 61.1% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Collaborative Arrangements Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Amgen R&D Cost-Share Liability — Total Carrying Value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 64.3 | -61.1% | Form 10-Q (filed 2026-08-05) ↗ |
| FY2024 | Dec 31, 2024 | 165 | -30.7% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 239 | -18.8% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 294 | -24.7% | Form 10-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 390 | -22.4% | Form 10-K (filed 2023-02-27) ↗ |
| FY2020 | Dec 31, 2020 | 503 | – | Form 10-K (filed 2022-02-28) ↗ |
Breakdown
What makes up amgen R&D Cost-Share Liability
Cite this data
StockData. (2026). BeOne Medicines Amgen R&D Cost-Share Liability ($M), annual FY2020–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/amgen-fin-liab-tot
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.